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Dangers 0/-
Indiscriminate 
Antibiotic 
Use 
J. c. Craea, B.S., Ph.D. 
T HE INTRODUCTION OF ANTI-
BIOTICS INTO THERAPY during 
the past ten years has provided a potent 
weapon against many diseases. The ap-
parent innocuous nature and low toxicity 
of these drugs qualified them for the label 
of "miracle" drugs. The antibiotics have 
altered therapeutics to an amazing de-
gree, and have done much in overcoming 
the dangers of some types of diseases. 
However, like high powered bullets, they 
can be dangerous if uncontrolled. Unlike 
most other drugs, antibiotics do not have 
a self-limiting cure-or-kill basis, but 
have ramifications of undesirable effects 
which may persist to provide health haz-
ards to an alarming degree not only to 
animals but to persons working with 
them. In recent years an increasing num-
ber of articles have appeared in the sci-
entific literature on hazards associated 
with indiscriminate widespread use of 
these potent drugs. While recognizing 
the undisputed role of antibiotics in pres-
ent day therapy, the subject of this re-
port is concerned with undesirable ef-
fects and an evaluation of what present 
indiscriminate use of antibiotics can lead 
to. 
Von Oettingen (32) of the National 
Institute of Health summarized these 
dangers in the 1954-55 Antibiotics An-
nual with the following: "Antibiotics 
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should not be used indiscriminately; they 
must be carefully selected for various 
types of infections and patients treated 
with antibiotics should be watched care-
fully for the appearance of side reac-
tions .... Furthermore, it appears likely 
that their use for promoting the growth 
of young domestic animals may also re-
sult in the production of resistant bac-
terial strains of at least the bacteria har-
bored by these animals. Thus, it is ap-
parent that antibiotic therapy is a power-
ful weapon in our fight against infec-
tious diseases; but there is real danger 
that this weapon be dulled by indis-
criminate use and by not restricting its 
use for curative purposes only and to 
those cases where it is really indicated." 
Unfortunately it is difficult to accumu-
late information on the extent of dam-
age produced by the widespread use of 
these drugs in home use of veterinary 
products. The disease treated is many 
times guessed at, dosage is uncertain and 
some of the consequences of irrational 
therapy, often more serious than the con-
dition treated can be ascertained only by 
clinical and laboratory tests. The infor-
mation presented here is drawn from a 
large number of clinical and laboratory 
findings in the fields of human and vet-
erinary medicine. There is a serious gap 
in our knowledge of findings under field 
conditions. Although statements are 
made citing lack of evidence of toxic or 
resistance manifestations under field 
conditions, these are essentially negative 
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arguments which really state that these 
factors were not tested. 
It would be impossible to assay all 
the factors of residual damage through 
indiscriminate use of antibiotics in the 
short space alloted here because of the 
complex nature of the problem. How-
ever, an attempt will be made to eluci-
date some of the problems in the coursp-
of this discussion. 
Complications of antibiotic therapy 
may be divided into two phases. First, 
the effects of the drug or microorganisms 
themselves, and secondly, the effects pro-
duced on the host, or the patient treated. 
Ideally, the drug should destroy the or-
ganism and not harm the patient. We do 
not have any ideal drugs. 
Problems relating to the effects on the 
microorganism are primarily those of: 
1. developing resistance to the drug; 2. 
the unbalancing of normal bacterial re-
lationships in the host which can give 
rise to "superinfections" by organisms 
not susceptible to the antibiotic used, or; 
3. the conversion of normally saprophy-
tic parasites to pathogens. Inadequate 
dosage or continual exposure to small 
doses of antibiotics can produce resist-
ance to that antibiotic, so that the prog-
eny of the resistant strain are unaffected 
by the antibiotic but are as fully capable 
of producing a disease in another indi-
vidual as is the sensitive strain. 
The most striking increase in bacterial 
resistance is shown by the micrococcus. 
In 1945, when penicillin was first intro-
duced, the incidence of resistance to peni-
cillin by these organisms, sampled at ran-
dom, was 14 percent. At the present 
time the incidence has increased to 75 
percent or higher. Maxwell Finland (1) 
of Boston City Hospital in 1953 tested 
500 strains of Staphylococcus aureus for 
sensitivity to nine antibiotics. He found 
that about three-fourths of the strains 
were resistant to penicillin, one-fourth 
were resistant to chlortetracycline (au-
reomycin®) and one-third were resistant 
to oxytetracycline (terramycin®). There 
was no close correlation between the 
source of the strains and their antibiotic 
resistance. The fecal strains, however, 
included a higher proportion of strains 
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resistant to penicillin, chlortetracycline 
and oxytetracycline than did those from 
any other source. His data suggests that 
while previous antibiotic therapy of any 
given patient may be an important factor 
in the occurrence of strains resistant to 
that antibiotics, the widespread use of 
antibiotics may be of equal or greater 
importance in the increase of incidence 
of staphylococci that are resistant to 
those antibiotics. Such strains may be-
come or l'emain pathogenic and retain 
their resistdnce when they are dissemi-
nated and aC4uired by patients who have 
themselves not received such antibiotics. 
The increase in resistance of staphy-
lococci to antibiotics with time is pre-
sented in Table 1. This is based primarily 
on the work of Kirby and Ahern (2). 
EMERGENCE OF ORGANISMS RESISTANT 
TO ANTIBIOTICS 
Drug Aug. '51-May '52 Jan.-Apr. '53 
1946-14.1 % 
Penicillin 1947 -38';!, 
1948-59'/0 
Chlortetracycline 
(Aureomycin) 
Oxytetracycline 
(Terramycin) 
Chloramphenicol 
(Chloromycetin) 
Bacitracin 
Erythromycin 
(Mayo Clinic) 
73% 68% 
42 61 
42 61 
20 6 
3 5 
2 
Mar. 53-0. Mar. '54-7'!c 
Table I. Note increase in resistant organisms 
since 1946. 
The changes in resistance shown for pen-
icillin from 1946 to 1948 are from other 
sources. The decrease in resistance of 
penicillin for 1953 may be attributed to 
the increased use of other antibiotics. 
The decrease in resistance to chloram-
phenicol for the same period may be at-
tributed to the decrease in use of this 
drug following reports of development of 
agranulocytosis. 
The serious consequences of infections 
with antibiotic resistant strains may be 
seen in Figure 1. Gagne (3) in 1955 re-
ported on staphylococcal pneumonia in 
infancy, with a report of 40 autopsied 
cases. The interesting thing here is that 
although these 40 cases were reported 
between 1951 and 1954 the incidence 
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Mortality in staphylococcal 
septicemia was reduced 
considerably with the advent 
of penicillin therapy. Emergence 
of resistant staphylococci, ilowever, 
has resulted in an incidence 
of fatal infections approaching 
previous high levels. (After Spink) 
Fig, 1. Reproduced by courtesy of Parke, Davis & Company's Therapeutic Notes 
showed a marked yearly increase; 5 cases 
1951, 8 in 1952, 11 in 1953 and 16 in 1954. 
The tragedy in this situation may be 
seen in fhat 10 of the 40 children were 
hospitalized for conditions of a non-in-
fectious nature (malnutrition, dematitis, 
icterus, harelip, pyloric stenosis and 
anemia. Fatal pneumonia resulted from 
contamination in the hospital wards. He 
concluded that this disease is apparently 
increasing in frequency in infants and that 
it seems to be due to a wide dissemination 
of highly virulent and antibiotic resistant 
strains of staphylococcus. 
The effects of resistant staphylococci 
were summarized in a lead article in 
Lancet (4) November 1954 with the fol-
lowing: "Penicillin, now a plentiful drug, 
is no longer the drug of choice for treat-
ing staphylococcal infections arising in 
hospitals. Virtually all such staphylo-
cocci are resistant to penicillin and nearly 
three-fourths of them are also resistant to 
streptomycin, aureomycin and terramy-
cin. Penicillin's usefulness outside the 
hospital is also questioned. Of staphy-
lococci isolated from out-patients, 24 to 
37 percent have proved to be penicillin 
resistant." 
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The carrier rate for penicillin-resistant 
staphylococci appears to be higher among 
hospital workers than control groups. 
Wilson (5) reported in 1952 that where 
11 to 25 percent of a control group 
of dormitory residence girls were re-
sistant carriers, that 74 percent were 
carried by the medical staff. This was an 
increase from 46 percent in 1947. Fre-
quent exposure to resistant sources of in-
fection, such as animal handlers using 
antibiotics 01' veterinarians must be kept 
in mind as possible sources of antibiotic 
resistant sources of infection not only for 
themselves but their families as well. The 
promiscuous use of these drugs is not 
without risk. Studies of changes in sensi-
tivity to erythromycin at the Mayo Clinic 
(6) over a two-year period (1952-53) 
showed that 37 of one-thousand patients 
had infections with resistant strains. Ad-
mittedly this is not a high ratio, but is 
significant since there were two the first 
year and 35 the second. In 25 patients 
the resistant strains presumably origi-
nated in carriers. 
Other types of organisms have also 
shown development of resistant strains. 
Wright (7) described in 1954 the sus-
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ceptibility of pseudomonas to 10 antibio-
tics and found, "A comparision of re-
cently isolated strains with those isolated 
in 1949 showed a significant increase in 
the incidence of resistance to chlortetra-
cycline, streptomycin, tetracycline and 
neomycin." The increase of resistance to 
tetracycline and neomycin is believed to 
be the result of cross-resistance with 
chlortetracycline and streptomycin, re-
spectively. "The resistance of the strains 
to any of the antibiotics tested could not 
be correlated with a history of previous 
treatment of the patient with homologous 
or other antimicrobial agents." 
In a report in 1953, Schalm and Woods 
(8) pointed out in a review of their work 
and of others that in the mastitis com-
plex there has been a shift in dominance 
from Streptococcus agalactiae to Micro-
coccus pyogenes and an increasing num-
ber of other organisms incriminated as 
agents involved in the mastitis complex. 
This has been attributed to extensive use 
and the improper administration of intra-
mammary therapy. In a study of over 
15,000 milk samples submitted by prac-
ticing veterinarians over a 6 year 
period, Packer (33) found mastitis 
organisms in 36.6 percent of the samples. 
It is interesting to note that Staphylo-
coccus aureus was present in 72.6 per-
cent of samples yielding mastitis or-
ganisms, Streptococcus agalactiae in 7.78 
percent, Streptococcus pyogenes in one 
sample, and Pasteurella multocida in 0.71 
percent. 
In addition to the selective elimination 
of antibiotic sensitive forms of many 
common pathogens and the emergence 
of resistant variants as the cause of dis-
ease, Rantz (9) has pointed out the in-
creasingly frequent occurrence of infec-
tion by organisms which were virtually 
unknown a few years ago as causes of 
disease. This is the second type of effect, 
or what is called "superinfection." Speare 
(10) and others (11) have pointed out 
the increasing occurrence of pseudomem-
branous enterocolitis as a fatal postoper-
ative complication. This complication ap-
pears to be related to the emergence of 
antibiotic-resistant strains of Micrococ-
cus pyogenes. In almost all recent re-
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ports, pure cultures of this organism re-
sistant to penicillin, streptomycin, chlor-
tetracycline and oxytetracycline have 
been found in the stools and intestinal 
lesions of these patients. This problem 
has been related to the upset in balance 
of the normal flora of the intestinal tract. 
Tyson (12) reported that daily oral doses 
of 7.5 to 3 Gm. of terramycin® admini-
stered for one to two weeks in patients 
without gastrointestinal disease showed 
that the essential bacteriologic change 
was a replacement of Escherichia coli by 
entercococci, proteus and yeast. Terra-
mycin given alone resulted in increased 
resistance of certain bacteria to auromy-
cin® and chloramphenicol as well as to 
terramycin. Sieburth (13) reported that 
no members of the genus Proteus were 
detected in the intestinal contents of 
turkey poults not receiving antibiotics; 
after terramycin was added to the basal 
diet the number of coliforms were 
greatly reduced while strains of proteus 
became established. It was suggested that 
terramycin resistant proteus may be-
come established in the intestinal tract of 
turkey poults receiving terramycin sup-
plements as a result of elimination or re-
duction in numbers of the terramycin 
susceptible proteus antagonists. In ex-
perimental studies of terramycin in rats 
Scaletti (14) found that the effect of 
terramycin was independent of the 
ration and markedly increased the 
numbers of proteus species with all ra-
tions. 
Poth (15) has described a possible 
mechanism by which proteus and staphy-
lococcal organisms might emerge to pro-
duce the coliformic syndrome through 
suppression of the normal intestinal sau-
rophytes by antibiotics. This is describ~d 
in Figure 2. Possible sites of secondary 
infections arising from coliform organ-
isms are shown in Figure 3. 
In a summary of side effects of terra-
mycin therapy, Hay (16) reported that 
side-effects other than mild gastrointest-
inal upsets were observed in 8 percent 
of 603 patients treated with terramycin 
in children the dose was 20 mg./kg. / day 
x 5, in those 12 years of age or over the 
dose was 2 Gm. per day). Copious fluids 
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POSSI8J.£ MECHANISM FOR 
DEVlLOPMENr OF 
CNOJ.£,q,IFOAMIC S YA/DROME 
Fig. 2. From the Journal of 
the American Medical Associa-
tion. 
_- -- Representation of what may be the sequence of events when 
the so-called choleriformic syndrome develops following oral admInistra-
tion of chlortetracycline or oxytetracycline. When the bacterial flora Is 
markedly suppressed on the third to fourth day, Proteus organisms grow 
out quite regularly and may cause diarrhea. Should a resistant Micro-
coccu~ pyogenes de~eloP that produces a potent enterotoxin, then nausea, 
VO~ItI~g, ~IOody. dIarrhea, hyperpyrexia, collapse, and death may result. 
ThIs sImplified dIagram cannot present all the possibilities. . . 
and supplements of vitamin B were 
given. The following syndromes associ-
ated with staphylococcal infections were 
found: 
2 cases of fulminating gastroenteroco1-
it is 
7 cases of sore throat with rash (sta-
phylococcal scarlet fever syndrome) 
8 cases of sore throats without rash 
1 case af balanitis with scarletina 
3 cases of urinary infection 
Other syndromes: 
24 cases of fever 
3 urticarial lesions 
4 cases of transient erythema 
The report on superinfections might 
properly be included also as an effect on 
the host since the consequences of bac-
terial resistance are found there. 
The problems relating to the host are 
many: effects on metabolism, interfer-
ence with antibody formation, drug sen-
sitivity which is of great importance and 
very serious, blood dyscrasias and mask-
ing of signs and symptoms in disease. 
Calesnick (17) found in studies done 
with radioactive iodine that antibiotics 
produce an anti-thyroid effect in ex peri-
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mental rats. Stevens (18) demonstrated 
that penicillin, dihydrostreptomycin, 
aureomycin and terramycin are all cap-
able of severely depressing the primary 
immune response to a soluble protein 
antigen in the rabbit. In laboratory 
studies in rats and mice Slanetz (19) 
found that feeding aureomycin, terramy-
cin, chloramphenicol, antibiotic residues 
and other substances had a significant 
influence on antibody production. Feed-
ing antibiotics for relatively short per-
iods resulted in increased antibody pro-
duction, but prolonged feeding of anti-
biotics and antibiotic residues appeared 
to interfere with the production of anti-
bodies. The adverse effect of prolonged 
feeding of antibiotics could be counter-
acted in part by supplementing the stock 
diet with yeast, certain B factors, or leci-
thin. 
Manheim (20) presented data on 300 
patients who developed anorectal com-
plications as a direct result of oral treat-
ment with aureomycin, terramycin or 
chloramphenicol for a variety of condi-
tions. The complications were far more 
annoying and in some instances were 
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Fig. 3. Reproduced by courtesy of Parke, Davis & Company's Therapeutic Notes. 
more serious than the original conditions 
for which the drugs were given. Fifteen 
patients required surgery because of the 
complications that had developed (crypt 
abscesses, fistulas and anal ulcers). 
Treatment had been difficult and more 
than two-thirds of the patients developed 
recurrences of the anorectal compli-
cations after apparent cure, although the 
drugs were not again administered. 
Some had recurrences for over 2 years. 
There seems to be no correlation be-
tween the total dose of the antibiotic and 
either the onset or severity of the compli-
cations. One patient took aureomycin 
lozenges for 1 day for a mild sore 
throat and had recurrent anorectal 
symptoms for over 2 years. Two-thirds 
of the patients never had previous ano-
rectal disease. 
In a broad sense the acquisition of 
sensitivity to antibotics probaby presents 
the most serious problem as a health 
hazard. As more and more exposure to 
antibiotics is made, deliberately or in-
advertently, the more we can expect the 
problem to recur. Rostenberg (21) stated 
the problem thus in regard to sensiti-
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zation, "It is well to realize the ubiquity 
of use and the casualness of attitude to-
ward the prescribing of the antibiotics, 
especially the newer, broad spectrum 
ones. Parenthetically, it appears that the 
medical profession is now beginning to 
reap its harvest from a population allerg-
ically sensitized to penicillin. It may, 
therefore, not be amiss to consider in 
some detail the various types of cutan-
eous reactions that have so far been re-
ported developing after antibiotic ther-
apy. We should also like to predict that 
as yet undescribed ones and increasingly 
severe ones will make their appearance 
as more and more of the population be-
come exposed." In a report on penicillin 
sensitivity reactions Strauch (22) de-
scribed 33 cases of penicillin reactions 
severe enough to warrant hospitalization. 
In many instances the reaction was more 
troublesome than the primary disease. 
Included was a fatal anaphylactoid 
reaction in a 6-week-old infant that had 
never received penicillin before, the 
mother had penicillin without reaction 
and there was no family history of al-
lergy. 
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Therefore BETTER for 
ACTIVE Immunity Against Erysipelas 
rhusigen 
Lysed-therefore releases its antigens 
speedily and readily, instead of locking 
them up in the unruptured cells, as do most 
erysipelas baderins. 
Avoids the need to use live culture, hence can not 
infect premises. 
Uses a 2 cc. dose instead of the 5 cc's required 
by other bacterins. 
Produces full immunity within two weeks. 
This full immunity persists for at least eight months, 
possibly longer. 
Immunizing capacity not affected by simultaneous use of 
anti-swine-erysipelas serum, if indicated for immediate protection. 
20 cc. vial (10 doses) code: Baryp 
100 ce. vial (50 doses) code: Balum 
Pitman-Moore Co. 
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ALLIED LABORATORIES, INC. 
Indianapolis 
*Trode Mark name for Erysipelas Bacterin (Lysate) P.-M. Co. Sio. 914: 
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Since an anaphylactic reaction re-
quires previous sensitization, one might 
speculate on the insidious nature by 
which a reaction might arise in an indi-
vidual not knowingly exposed to the 
sensitizing drug. It should lead to a con-
sideration of whether free access to the 
antibiotics should be allowed to continue. 
In 1955 the Food and Drug Administra-
tion (23) tested 474 samples of fresh 
fluid milk (both raw and pasteurized) 
from 16 areas in the United States, for 
their antibiotic content. Concentrations 
of from 0.003 to 0.08 units per milliliter 
were found in 55 (11.6 percent) sam-
ples. The reckless use of the antibiotics 
can produce effects far removed from the 
animal treated. Barr (24) has shown 
that the uncontrolled use of broad spec-
trum antibiotics has produced an in-
crease in antibiotic resistant calf scour 
producing organisms. As more and more 
organisms become resistant, the less 
valuable become the antibiotics. 
Once sensitivity is acquired, severe re-
actions may follow with even relatively 
minute quantities of antibiotics. A severe 
anaphylactic reaction occurred following 
the ingestion of one tablet of penicillin 
for a sore throat (25). 
That hypersensitivity to a drug can be 
serious may be seen in two other unusual 
cases reported: Coleman (26) reported 
production of severe reactions in hyper-
sensitive individuals through uninten-
tional administration of penicillin with 
contaminated syringes used for other 
drugs, or from boiling syringes in peni-
cillin contaminated sterilizers. Another 
(27) was of an individual so sensitive 
that he experienced tightness of the chest 
in a drug store when the pharmacist was 
changing penicillin tablets from one 
bottle to another. 
Weinstein (28) reported on the prob-
lem of superinfection of 3,095 hospital-
ized patients who received one or more 
antibiotics as treatment for an infectious 
disease. The over-all incidence of super-
infection was 2.19 percent. The second-
ary infection often affected the same 
organs as those affected by the primary 
disease. A benign, self-limiting disease 
may be converted by the appearance of 
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superinfection into a serious, prolonged, 
and even fatal one. The presently avail-
able antibacterial drugs are often ineffec-
tive against the organisms responsible for 
the superinfection. These occurred after 
treatment of the primary infection with 
penicillin, aureomycin, streptomycin and 
pen i c i 11 in-streptomycin combination. 
Weinstein also found that where antibio-
tics were administered prophylactically, 
(a practice to be deplored) that the fre-
quency of superinfection after prophy-
laxis of respiratory poliomyelitis was 
more than seven times the average for 
the whole group and after prophylaxis 
of measles it was over 16 times higher 
than the average. 
One additional factor in the compli-
cations of the use of antibiotic drugs is 
that reported by Tompsett (29). The 
masking of signs and symptoms as a re-
sult of antimicrobial therapy is well 
known in that suppression of clinical 
manifestations of infection and negative 
blood cultures can be obtained without 
actually producing a cure. Also anti-
microbial therapy can obscure signs of 
localized infection which require further 
management, usually surgery. 
A few years ago chloramphenicol was 
incriminated in a number of cases as pro-
ducing fatal aplastic anemia. This disease 
has fortunately been rare, but has also 
been attributed to other antibiotics and 
other drugs. 
Research in the development of drugs 
effective against molds and yeasts has 
been stimulated by the appearance of 
moniliasis or thrush (Candida albicans) 
as a sometimes fatal, but more frequently 
annoying, side effect in antibiotic ther-
apy. Drug therapy of these diseases has 
been ineffectual until recently and still 
leaves much to be desired. 
A distressing report was recently 
issued in Lancet by Thomas (30) against 
an old enemy of man - tuberculosis. 
Nine patients who had received no pre-
vious chemotherapy for tuberculosis 
were found to be infected with drug-re-
sistant tuberculosis bacilli: 4 to strep-
tomycin, 4 to Para-Aminosalicylic acid, 
and one to both. At least three were 
* Antibiotic (continued on page 82) 
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cells which results in erosions and ulcers. 
Blindness results in the following man-
ner: The virus is carried to the mucous 
membrane of the eye where it causes 
severe reddening. This is followed by a 
sera-mucous discharge from the eyes. 
This mucous may cause the eyelids to 
stick together and thus the animal can't 
see. 
ARSENICAL & LEAD POISONING 
This can occur in any species of ani-
mal if they ingest the chemical. These 
chemicals are absorbed into the blood 
stream and they are carried to the ner-
vous system. They affect the eye by caus-
ing the pupils to dilate, if these animals 
so affected get into bright light the retinal 
cells will become paralyzed and blind-
ness will result. 
The use of these chemicals in weed 
sprays, rodE:mt poisons, insecticides and 
paints has increased the incidence of this 
condition in animals. 
MISCELLANEOUS CAUSES 
There are a number of things that may 
affect the eye directly and cause blind 
ness. These are foreign bodies such as 
pieces of weeds, thorns, seeds and sticks; 
chemical irritants such as acids; scrathces 
such as those from a barbed wire fence 
or from bites as occurs in dogs. These 
conditions may also allow secondary in-
fections to enter the eye and produce 
blindness. 
Blindness may also result from con-
genital defects such as absence of one or 
both eyes, failure of development of op-
tic foramina as a result of vitamin A de-
ficiency and improper development of 
any part of the eye of the fetus. 
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known to have tuberculosis before the 
revalent drug was in general use, and it 
is presumed that their original bacilli 
were drug-sensitive and they were su-
perinfected with resistant bacilli. To 
them the future is drugless. 
Finally, an important economic prob-
lem is presented in the dairy industry. 
It is known (31) that there may be 
serious interference with lactic acid fer-
mentations if minute amounts of anti-
biotics are present in the milk. Since 
Iowa State College Veterinarian 
pasteurization does not destroy the anti-
biotics (or are not proven to be de-
stroyed) we can only surmise at the 
amount of antibiotics disseminated un-
knowingly (or willfully) to the general 
population. 
There is a definite need in the field of 
veterinary medicine for more infor-
mation on the changing picture in anti-
biotic therapy. This is particularly true 
for studies under field conditions, where 
the information is most needed and least 
available. Factual information, sufficient 
in quantity to be statistically significant 
and carefully balanced with control 
studies, would assist immeasurably in 
providing more rational therapeutic re-
gimes than are now used. It would also 
reduce the deplorable practice of em-
pirical therapy which was reintroduced 
with the advent of sulfonamides and an-
tibiotics. Since the practitioner is faced 
more and more with resistant strain dis-
eases, diagnosis before treatment is more 
imperative than ever. 
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A good anesthetic for birds of the para-
keet variety is ether. However it must be 
given by the intermittent method. Gen-
eral anesthetics are much better than is 
the use of local anesthetic such as pro-
caine. 
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